Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Congenital sideroblastic anemias.

Sylvia S Bottomley1

  • 1Hematology-Oncology Section (111J), University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. sylvia-bottomley@ouhsc.edu

Current Hematology Reports
|March 16, 2006
PubMed
Summary

Congenital sideroblastic anemias are rare disorders characterized by iron buildup in red blood cell mitochondria. Research is advancing our understanding of iron metabolism and heme synthesis for potential new treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

X-linked sideroblastic anemia in females.

Blood·2025
Same author

Engineered bacterial lipoate protein ligase A (lplA) restores lipoylation in cell models of lipoylation deficiency.

The Journal of biological chemistry·2024
Same author

SLC25A38 congenital sideroblastic anemia: Phenotypes and genotypes of 31 individuals from 24 families, including 11 novel mutations, and a review of the literature.

Human mutation·2021
Same author

Mutations in the iron-sulfur cluster biogenesis protein HSCB cause congenital sideroblastic anemia.

The Journal of clinical investigation·2020
Same author

Reduced-toxicity allogeneic hematopoietic stem cell transplantation in congenital sideroblastic anemia.

Clinical case reports·2018
Same author

The phenotypic spectrum of germline <i>YARS2</i> variants: from isolated sideroblastic anemia to mitochondrial myopathy, lactic acidosis and sideroblastic anemia 2.

Haematologica·2018

Area of Science:

  • Hematology
  • Genetics
  • Molecular Biology

Background:

  • Congenital sideroblastic anemias (CSAs) are uncommon inherited disorders.
  • Diagnosis is based on pathological iron deposits within erythroblast mitochondria.
  • CSAs are heterogeneous, with some linked to known molecular defects and others identified by clinical presentation.

Purpose of the Study:

  • To review the current understanding of congenital sideroblastic anemias.
  • To highlight advancements in comprehending heme biosynthesis and iron metabolism in erythroid cells.
  • To identify future research directions in mitochondrial iron homeostasis and its regulation of heme synthesis.

Main Methods:

  • Literature review of congenital sideroblastic anemias.
  • Analysis of research on molecular defects and clinical features.
  • Synthesis of findings related to heme biosynthesis and iron metabolism.

Main Results:

  • Elucidation of specific molecular defects has improved understanding of heme biosynthesis.
  • The porphyrin synthetic pathway is increasingly understood.
  • Mechanisms of mitochondrial and cellular iron homeostasis are a key area for future research.

Conclusions:

  • Understanding the molecular basis of CSAs has advanced knowledge of erythroid iron and heme metabolism.
  • Further research into iron homeostasis is crucial for understanding CSA pathogenesis.
  • New therapeutic strategies may emerge from a deeper understanding of these mechanisms, though current treatments remain largely supportive.

Related Experiment Videos